Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 31, 2021
Assets
Cash and cash equivalents	$ 110,112	$ 189,711
Accounts receivable, net of allowance for credit losses	122,440	110,050
Financing receivables, net of allowance for credit losses	127,173	141,049
Variable consideration receivables, net of allowance for credit losses	43,040	44,218
Inventories	33,422	26,924
Prepaid expenses	14,418	11,802
Film assets, net of accumulated amortization	6,026	4,241
Property, plant and equipment, net of accumulated depreciation	252,309	260,353
Investment in equity securities	1,092	1,087
Other assets	16,986	17,799
Deferred income tax assets, net of valuation allowance	13,958	13,906
Goodwill	39,027	39,027
Other intangible assets, net of accumulated amortization	21,821	23,080
Total assets	801,824	883,247
Liabilities
Accounts payable	19,849	15,943
Accrued and other liabilities	105,776	111,896
Deferred revenue	75,951	81,281
Revolving credit facility borrowings, net of unamortized debt issuance costs		2,472
Convertible notes, net of unamortized discounts and debt issuance costs	224,379	223,641
Deferred income tax liabilities	17,642	17,642
Total liabilities	443,597	452,875
Commitments and contingencies (see Note 8)
Non-controlling interests
Non-controlling interests	742	758
Shareholders' equity
Capital stock common shares - no par value. Authorized - unlimited number. 58,750,922 issued and outstanding (December 31, 2021 - 58,653,642 issued and outstanding)	391,107	409,979
Other equity	174,668	174,620
Statutory surplus reserve	3,932	3,932
Accumulated deficit	(272,022)	(234,975)
Accumulated other comprehensive (loss) income	(6,755)	2,527
Total shareholders' equity attributable to common shareholders	290,930	356,083
Non-controlling interests	66,555	73,531
Total shareholders' equity	357,485	429,614
Total liabilities and shareholders' equity	$ 801,824	$ 883,247